Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

157 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Myeloablative conditioning in cord blood transplantation for acute myeloid leukemia patients is efficacious only until age 55.
Oshima S, Arai Y, Kondo T, Yano S, Hirabayashi S, Uchida N, Onizuka M, Miyakoshi S, Tanaka M, Takahashi S, Hayashi M, Kawakita T, Uehara Y, Ota S, Izumi T, Sawa M, Nishida T, Katayama Y, Nagafuji K, Kato K, Ichinohe T, Atsuta Y, Yanada M. Oshima S, et al. Among authors: miyakoshi s. Bone Marrow Transplant. 2025 Jan 21. doi: 10.1038/s41409-025-02508-2. Online ahead of print. Bone Marrow Transplant. 2025. PMID: 39838078
Allogeneic hematopoietic stem cell transplantation using reduced intensity conditioning regimen for patients with acute myeloid leukemia not in complete remission.
Shimomura Y, Kitamura T, Yanada M, Mizuno S, Kondo T, Yoshihara S, Tanaka M, Inai K, Katayama Y, Onizuka M, Fukuda T, Nakamae H, Kurokawa M, Yano S, Nara M, Masuko M, Miyakoshi S, Eto T, Yoshimitsu M, Ishimaru F, Kanda J, Atsuta Y, Konuma T. Shimomura Y, et al. Among authors: miyakoshi s. Cytotherapy. 2024 Nov 17:S1465-3249(24)00937-X. doi: 10.1016/j.jcyt.2024.11.012. Online ahead of print. Cytotherapy. 2024. PMID: 39625431
Machine Learning Prediction Model for Neutrophil Recovery after Unrelated Cord Blood Transplantation.
Kuwatsuka Y, Kasajima R, Yamaguchi R, Uchida N, Konuma T, Tanaka M, Shingai N, Miyakoshi S, Kozai Y, Uehara Y, Eto T, Toyosaki M, Nishida T, Ishimaru F, Kato K, Fukuda T, Imoto S, Atsuta Y, Takahashi S. Kuwatsuka Y, et al. Among authors: miyakoshi s. Transplant Cell Ther. 2024 Apr;30(4):444.e1-444.e11. doi: 10.1016/j.jtct.2024.02.001. Epub 2024 Feb 7. Transplant Cell Ther. 2024. PMID: 38336299
Selection of Cord Blood Unit by CD34+ Cell and GM-CFU Numbers and Allele-Level HLA Matching in Single Cord Blood Transplantation.
Morishima Y, Watanabe-Okochi N, Kai S, Azuma F, Kimura T, Matsumoto K, Hatasa S, Araki N, Miyamoto A, Sekimoto T, Minemoto M, Ishii H, Uchida N, Takahashi S, Tanaka M, Shingai N, Miyakoshi S, Kozai Y, Onizuka M, Eto T, Ishimaru F, Kanda J, Ichinohe T, Atsuta Y, Takanashi M, Kato K. Morishima Y, et al. Among authors: miyakoshi s. Transplant Cell Ther. 2023 Oct;29(10):622-631. doi: 10.1016/j.jtct.2023.07.022. Epub 2023 Aug 2. Transplant Cell Ther. 2023. PMID: 37536453 Free article.
Unrelated female-to-male bone marrow transplantation would be preferred over cord blood transplantation in male patients.
Tamaki M, Akahoshi Y, Okada Y, Uchida N, Tanaka M, Doki N, Sawa M, Maruyama Y, Ueda Y, Miyakoshi S, Katayama Y, Kawakita T, Kimura T, Onizuka M, Fukuda T, Atsuta Y, Yanagisawa R, Yakushijin K, Kanda J, Nakasone H. Tamaki M, et al. Among authors: miyakoshi s. Cytotherapy. 2023 Nov;25(11):1220-1228. doi: 10.1016/j.jcyt.2023.06.002. Epub 2023 Jun 20. Cytotherapy. 2023. PMID: 37341665
Should a matched sibling donor still be considered the primary option for allogeneic hematopoietic cell transplantation in patients over 50 years of age with myelodysplastic syndrome?
Konuma T, Itonaga H, Ishiyama K, Doki N, Uchida N, Sawa M, Katayama Y, Tanaka M, Ueda Y, Onizuka M, Miyakoshi S, Ozawa Y, Fukuda T, Matsuoka KI, Tanaka J, Kimura T, Ichinohe T, Atsuta Y. Konuma T, et al. Among authors: miyakoshi s. Bone Marrow Transplant. 2023 Aug;58(8):893-906. doi: 10.1038/s41409-023-01997-3. Epub 2023 May 8. Bone Marrow Transplant. 2023. PMID: 37156881 Free PMC article.
Advantages of Higher Busulfan Dose Intensity in Fludarabine-Combined Conditioning for Patients with Acute Myeloid Leukemia Undergoing Cord Blood Transplantation.
Shibata S, Arai Y, Kondo T, Mizuno S, Harada K, Miyakoshi S, Uchida N, Maruyama Y, Eto T, Katsuoka Y, Matsue K, Nishiwaki K, Takada S, Doki N, Itoh M, Nagafuji K, Kawakita T, Tanaka J, Fukuda T, Atsuta Y, Yanada M. Shibata S, et al. Among authors: miyakoshi s. Transplant Cell Ther. 2023 May;29(5):332.e1-332.e11. doi: 10.1016/j.jtct.2023.02.004. Epub 2023 Feb 14. Transplant Cell Ther. 2023. PMID: 36796517 Free article.
Comparison of transplant outcomes between haploidentical transplantation and single cord blood transplantation in non-remission acute myeloid leukaemia: A nationwide retrospective study.
Matsuda K, Konuma T, Fuse K, Masuko M, Kawamura K, Hirayama M, Uchida N, Ikegame K, Wake A, Eto T, Doki N, Miyakoshi S, Tanaka M, Takahashi S, Onizuka M, Kato K, Kimura T, Ichinohe T, Takayama N, Kobayashi H, Nakamae H, Atsuta Y, Kanda J, Yanada M. Matsuda K, et al. Among authors: miyakoshi s. Br J Haematol. 2023 Apr;201(1):106-113. doi: 10.1111/bjh.18530. Epub 2022 Oct 25. Br J Haematol. 2023. PMID: 36281887
Salvage single-unit unrelated cord blood transplantation for graft failure following initial allogeneic transplantation in adult acute myeloid leukemia: trends in outcomes over the past 20 years.
Konuma T, Harada K, Kondo T, Masuko M, Uchida N, Yano S, Kawakita T, Onizuka M, Ota S, Sakaida E, Miyakoshi S, Ozawa Y, Imamura Y, Kimura T, Kanda Y, Fukuda T, Atsuta Y, Yanada M; Adult Acute Myeloid Leukemia Working Group of the Japanese Society for Transplantation and Cellular Therapy. Konuma T, et al. Among authors: miyakoshi s. Bone Marrow Transplant. 2022 Dec;57(12):1848-1850. doi: 10.1038/s41409-022-01840-1. Epub 2022 Oct 4. Bone Marrow Transplant. 2022. PMID: 36195770 No abstract available.
157 results